These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37630200)

  • 1. Exploring Species-Specificity in TLR4/MD-2 Inhibition with Amphiphilic Lipid A Mimicking Glycolipids.
    Borio A; Holgado A; Passegger C; Strobl H; Beyaert R; Heine H; Zamyatina A
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition.
    Akashi S; Nagai Y; Ogata H; Oikawa M; Fukase K; Kusumoto S; Kawasaki K; Nishijima M; Hayashi S; Kimoto M; Miyake K
    Int Immunol; 2001 Dec; 13(12):1595-9. PubMed ID: 11717200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatides are endogenous ligands for the TLR4-MD-2 complex.
    Su L; Athamna M; Wang Y; Wang J; Freudenberg M; Yue T; Wang J; Moresco EMY; He H; Zor T; Beutler B
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34290146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa.
    Walsh C; Gangloff M; Monie T; Smyth T; Wei B; McKinley TJ; Maskell D; Gay N; Bryant C
    J Immunol; 2008 Jul; 181(2):1245-54. PubMed ID: 18606678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
    Ohto U; Fukase K; Miyake K; Shimizu T
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA.
    Meng J; Drolet JR; Monks BG; Golenbock DT
    J Biol Chem; 2010 Sep; 285(36):27935-43. PubMed ID: 20592019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.
    Cochet F; Peri F
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-palmitoyl-D-glucosamine, a Natural Monosaccharide-Based Glycolipid, Inhibits TLR4 and Prevents LPS-Induced Inflammation and Neuropathic Pain in Mice.
    Iannotta M; Belardo C; Trotta MC; Iannotti FA; Vitale RM; Maisto R; Boccella S; Infantino R; Ricciardi F; Mirto BF; Ferraraccio F; Panarese I; Amodeo P; Tunisi L; Cristino L; D'Amico M; Di Marzo V; Luongo L; Maione S; Guida F
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
    Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
    Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
    Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
    J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
    Maeshima N; Fernandez RC
    Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
    Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
    Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally constrained lipid A mimetics for exploration of structural basis of TLR4/MD-2 activation by lipopolysaccharide.
    Artner D; Oblak A; Ittig S; Garate JA; Horvat S; Arrieumerlou C; Hofinger A; Oostenbrink C; Jerala R; Kosma P; Zamyatina A
    ACS Chem Biol; 2013 Nov; 8(11):2423-32. PubMed ID: 23952219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
    Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
    J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants.
    Strobl S; Hofbauer K; Heine H; Zamyatina A
    Chemistry; 2022 Jun; 28(35):e202200547. PubMed ID: 35439332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.